Woodline Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,163
| Closed | -$36K | – | 585 |
|
|
2024
Q2 | $36K | Buy |
+12,163
| New | +$36K | ﹤0.01% | 541 |
|
|
2022
Q2 | – | Sell |
-136,910
| Closed | -$1.34M | – | 792 |
|
|
2022
Q1 | $1.34M | Sell |
136,910
-533,729
| -80% | -$5.2M | 0.02% | 446 |
|
|
2021
Q4 | $9.59M | Buy |
670,639
+273,823
| +69% | +$3.92M | 0.14% | 205 |
|
|
2021
Q3 | $7.95M | Hold |
396,816
| – | – | 0.13% | 188 |
|
|
2021
Q2 | $8.73M | Buy |
396,816
+141,914
| +56% | +$3.12M | 0.16% | 148 |
|
|
2021
Q1 | $8.66M | Sell |
254,902
-176,185
| -41% | -$5.98M | 0.19% | 137 |
|
|
2020
Q4 | $17.3M | Buy |
+431,087
| New | +$17.3M | 0.46% | 69 |
|